Minimal monitoring program achieves SVR in hepatitis C

In a minimal monitoring – or “Minmon” – study, patients given a full regimen for hepatitis C virus and then remotely monitored achieved 95% sustained virologic response, according to a presenter at The Liver Meeting Digital Experience.“Though this trial was designed before the COVID pandemic, I like to think of it as COVID-proof or COVID-friendly even. COVID really has required us to pivot clinical programs to minimizing contact and remote approaches which in theory is the essence of the Minmon strategy,” Sunil Solomon, PhD, MPH, MBBS, from Johns Hopkins,Read More

Share on facebook
Share on twitter
Share on linkedin